Bal, A.
Pichon, M.
Picard, C.
Casalegno, J. S.
Valette, M.
Schuffenecker, I.
Billard, L.
Vallet, S.
Vilchez, G.
Cheynet, V.
Oriol, G.
Trouillet-Assant, S.
Gillet, Y.
Lina, B.
Brengel-Pesce, K.
Morfin, F.
Josset, L.
Funding for this research was provided by:
Fondation Innovations en Infectiologie
Article History
Received: 14 February 2018
Accepted: 16 October 2018
First Online: 29 October 2018
Ethics approval and consent to participate
: This single center retrospective study received approval from HCL board of the French data protection authority (<i>Commission Nationale de l’Informatique et des Libertés</i>) and is registered with the national data protection agency (number 17–024). Respiratory samples were collected for regular disease management during hospital stay and no additional samples were taken for this study. In accordance with French legislation relating to this type a study, a written informed consent from participants was not required for the use of de-identified collected clinical samples (Bioethics law number 2004–800 of August 6, 2004). During their hospitalization in the HCL, patients are made aware that their de-identified data including clinical samples may be used for research purposes, and they can opt out if they object to the use of their data.
: Not applicable.
: The authors declare that they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.